142 related articles for article (PubMed ID: 38468382)
1. Temporal trend analysis of acute hepatitis B virus infection in China, 1990-2019.
Han Y; Li Y; Wang S; Chen J; Zhang J
Epidemiol Infect; 2024 Mar; 152():e48. PubMed ID: 38468382
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Hepatitis B Collaborators
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
[TBL] [Abstract][Full Text] [Related]
3. Trends and age-period-cohort effect on incidence of hepatitis B from 2008 to 2022 in Guangzhou, China.
Zheng Z; Lin X; Huang Y; Zhang C; Zhang Z
Sci Rep; 2024 Jun; 14(1):13370. PubMed ID: 38862511
[TBL] [Abstract][Full Text] [Related]
4. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
Yao L; Lin S; Huang J; Wu Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
[TBL] [Abstract][Full Text] [Related]
5. Secular Trends of Acute Viral Hepatitis Incidence and Mortality in China, 1990 to 2019 and Its Prediction to 2030: The Global Burden of Disease Study 2019.
Su X; Zheng L; Zhang H; Shen T; Liu Y; Hu X
Front Med (Lausanne); 2022; 9():842088. PubMed ID: 35360747
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Incidence of Acute Hepatitis B in the Polish Population and Their Determinants.
Stawinska-Witoszynska B; Klos J; Moryson W; Wieckowska B
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440944
[No Abstract] [Full Text] [Related]
7. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
Cao G; Liu J; Liu M
Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
[TBL] [Abstract][Full Text] [Related]
8. Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years.
Niu D; Zhao Y; Wang J; Ye E; Huang J; Liu J; Huang X; Yue S; Hou X; Wu J
Ann Hematol; 2023 Sep; 102(9):2375-2386. PubMed ID: 37468671
[TBL] [Abstract][Full Text] [Related]
9. Long-term trends in the incidence of endometriosis in China from 1990 to 2019: a joinpoint and age-period-cohort analysis.
Feng J; Zhang S; Chen J; Yang J; Zhu J
Gynecol Endocrinol; 2021 Nov; 37(11):1041-1045. PubMed ID: 34519590
[TBL] [Abstract][Full Text] [Related]
10. Trends in the disease burden of HBV and HCV infection in China from 1990-2019.
Yue T; Zhang Q; Cai T; Xu M; Zhu H; Pourkarim MR; De Clercq E; Li G
Int J Infect Dis; 2022 Sep; 122():476-485. PubMed ID: 35724827
[TBL] [Abstract][Full Text] [Related]
11. Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age-period-cohort modeling study.
Ye E; Huang J; Wang J; Zhao Y; Niu D; Liu J; Huang X; Yue S; Hou X; Wu J
Cancer Med; 2023 Aug; 12(15):16517-16530. PubMed ID: 37306154
[TBL] [Abstract][Full Text] [Related]
12. Trends in disease burden of hepatitis B infection in Jiangsu Province, China, 1990-2021.
Fang K; Shi Y; Zhao Z; Zhao Y; Guo Y; Abudunaibi B; Qu H; Liu Q; Kang G; Wang Z; Hu J; Chen T
Infect Dis Model; 2023 Sep; 8(3):832-841. PubMed ID: 37520113
[TBL] [Abstract][Full Text] [Related]
13. Incidence trends of primary liver cancer in different geographical regions of China from 1978 to 2012 and projections to 2032: An age-period-cohort analysis.
Jiang L; Zhao N; Xu M; Pei J; Lin Y; Yao Q; Hu M; Zhu C
Int J Cancer; 2024 Feb; 154(3):465-476. PubMed ID: 37707172
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study.
Li M; Zu J; Shen M; Zhuang G; Chen S; Wang F; Zheng H; Zhang G
BMC Public Health; 2021 Feb; 21(1):388. PubMed ID: 33607996
[TBL] [Abstract][Full Text] [Related]
15. Long-term trends of HIV/AIDS incidence in India: an application of joinpoint and age-period-cohort analyses: a gendered perspective.
Shri N; Bhattacharyya K; Dhamnetiya D; Singh M; Jha RP; Patel P
Front Public Health; 2023; 11():1093310. PubMed ID: 37261236
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study.
Liu Z; Yang Q; Shi O; Ye W; Chen X; Zhang T
J Viral Hepat; 2018 Dec; 25(12):1543-1554. PubMed ID: 29851287
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B and C mortality from 1990 to 2019 in China: a Bayesian age-period-cohort analysis.
Yan M; Wu B
Ann Transl Med; 2022 Dec; 10(24):1384. PubMed ID: 36660613
[TBL] [Abstract][Full Text] [Related]
18. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.
La Torre G; Nicolotti N; de Waure C; Chiaradia G; Specchia ML; Mannocci A; Ricciardi W
Virol J; 2008 Jul; 5():84. PubMed ID: 18652653
[TBL] [Abstract][Full Text] [Related]
19. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status.
Cao G; Jing W; Liu J; Liu M
Hepatol Int; 2022 Dec; 16(6):1282-1296. PubMed ID: 36048317
[TBL] [Abstract][Full Text] [Related]
20. Incidence trend and age-period-cohort analysis of reported hepatitis C among residents aged 30 to 79 in northeastern China, 2008 to 2017.
Zhao Q; Jiang S; Li M; Yao L; Ma X; Li M; Wang C; Pan Y; Zhao H; Li B
Medicine (Baltimore); 2020 Sep; 99(36):e22005. PubMed ID: 32899048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
